Navigation Links
Temple researcher shows diabetes, blood pressure link to colon cancer recurrence, survival
Date:12/19/2012

8 to 2006 on 36,079 patients with colon cancer, including 7,024 patients (19.5 percent) who were identified as having metabolic syndrome. They analyzed the effect of metabolic syndrome and its components on colon cancer recurrence and overall survival, controlling for various sociodemographic factors, tumor factors, other medical conditions and cancer treatment received.

"Metabolic syndrome as a whole had no apparent effect on colon cancer recurrence or survival," said Dr. Esnaola, who is also an attending surgeon at Fox Chase Cancer Center. "When we teased out and analyzed the effect of each of its components, however, the data told a different story."

The researchers found that among patients with early stage disease, patients with diabetes or high blood pressure had a significantly greater risk of cancer recurrence rate and death after treatment. For example, 47.7 percent of patients who did not have diabetes were still alive five years after diagnosis compared to only 41.3 percent of patients with diabetes. When the researchers looked more closely, they also found that cancer recurrence rates at five years were approximately 8 percent higher in patients with diabetes or hypertension.

In contrast, the analysis showed that patients with abnormally high levels of lipids in the blood had a lower risk of recurrence and death from colon cancer. Overall, 39 percent of patients with normal lipid levels were still alive after five years, compared to 52.7 percent of patients with abnormal levels. Cancer recurrence rates were approximately 11 percentage points lower in patients with abnormal lipid levels.

"Although we did not have data on medication for these patients, we suspect that the higher survival and lower recurrence rates observed in patients with high lipid levels in our study group were likely due to the protective effects of statins," Dr. Esnaola said. Statins are drugs that are widely used to lower cholesterol and lipid
'/>"/>

Contact: Steven Benowitz
steven.benowitz@tuhs.temple.edu
215-707-4784
Temple University Health System
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Drug resistant leukemia stem cells may be source of genetic chaos, Temple scientists find
2. Temple scientists target DNA repair to eradicate leukemia stem cells
3. Templeton Foundation awards grant for meditation research
4. John Templeton Foundation grant supports Princeton neuroscientists to study cognitive control
5. Temple researchers show targeted cancer drug may stunt hearts ability to repair itself
6. Penn-Temple team discovers gatekeeper for maintaining health of cell energy source
7. MRIs reveal signs of brain injuries not seen in CT scans, UCSF/SFGH researchers report
8. Researchers find model system to study promising cancer drug
9. Way to make one-way flu vaccine discovered by Georgia State researcher
10. UNC researchers discover how hepatitis C virus reprograms human liver cells
11. Mayo Clinic researchers identify enzyme linked to prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 The Biofeedback ... a new distribution agreement with game development company ... the two groups to offer Zukor's Grind ... biofeedback and neurofeedback in European and international markets. ... developed expressly to be used as a biofeedback/neurofeedback ...
(Date:7/24/2014)... July 24, 2014 The North American air ... billion in 2014, and is expected to register a CAGR ... has been the biggest market for the air and missile ... U.S. market has witnessed budget cuts as well. , Browse ... defense radar market report, to get an idea of the ...
(Date:7/24/2014)... Steven Reinberg HealthDay ... Children covered by Medicaid, the publicly funded insurance program for ... more often than uninsured or privately insured youngsters, a U.S. ... than those with private insurance to visit for a reason ... survey conducted by the U.S. Centers for Disease Control and ...
(Date:7/24/2014)... News) -- Even though its use is often advised by ... does not help treat lower back pain, according to a ... was no more effective than a dummy pill for more ... Besides showing no effect in easing discomfort, the study also ... tied to back pain, nor did it improve patients, overall ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 While healthcare ... in providing quality interpretation services to non-English speakers within ... down. According to Common Sense Advisory, the language ... to $2.3 billion in 2016 (1); additionally, officials at ... to shift over to video remote interpreting ...
Breaking Medicine News(10 mins):Health News:Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive 2Health News:Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive 3Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 2Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 3Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 4Health News:Many Kids With Medicaid Use ER as Doctor's Office: CDC 2Health News:Many Kids With Medicaid Use ER as Doctor's Office: CDC 3Health News:Acetaminophen May Not Help Against Back Pain, Study Contends 2Health News:Acetaminophen May Not Help Against Back Pain, Study Contends 3Health News:Stratus Video Interpreting Predicts $1 Billion Market Shift to Video Remote Interpreting by 2016 as Court and Healthcare Systems Heed Cost-Effectiveness 2Health News:Stratus Video Interpreting Predicts $1 Billion Market Shift to Video Remote Interpreting by 2016 as Court and Healthcare Systems Heed Cost-Effectiveness 3Health News:Stratus Video Interpreting Predicts $1 Billion Market Shift to Video Remote Interpreting by 2016 as Court and Healthcare Systems Heed Cost-Effectiveness 4
... Supported Efficacy, Safety and Tolerability of ... with Schizophrenia -, TOKYO and PRINCETON, N.J., ... Squibb Company (NYSE: BMY ) announced today ... the supplemental New,Drug Application for the atypical antipsychotic ...
... be lifesavers, study suggsts , TUESDAY, Nov. 6 (HealthDay ... artery bypass graft (CABG) surgery reduces a patient,s risk ... the Cleveland Clinic, included more than 5,200 patients who ... overall incidence of post-operative stroke one year after surgery ...
... To help raise awareness about the,prevalence of ... serving our country, TriWest Healthcare Alliance has contributed,$50,000 ... TBI. "According to the Department of Defense, ... members sustaining injuries in the Global War,on Terror ...
... Focus on Growth Businesses, LEHIGH VALLEY, Pa., Nov. ... Chemie AG are in advanced discussions over Wacker,s,purchase of ... Systems (WPS) and Air Products Polymers (APP), including APP,s,vinyl ... and,Wacker 35 percent. As for WPS, Wacker owns 80 ...
... 7 The Disabled American,Veterans (DAV) is commending ... the largest increase in funding for the Department ... on Congress and the,Administration to support this important ... Military Construction and Veterans Affairs Appropriations bill,calls for ...
... QED International Associates Inc.,administrator for the HealthShares(TM) ... today announced that effective at the,opening of trading ... GIVN ) will replace Dade Behring Holdings, ... Index, and Inverness Medical Innovations,(Amex: IMA ) ...
Cached Medicine News:Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 2Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 3Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 4Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 5Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 6Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 7Health News:U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia 8Health News:TriWest Contributes $50,000 to Bob Woodruff Family Fund for Traumatic Brain Injury 2Health News:Air Products in Advanced Discussions With Wacker Over Polymers Business 2Health News:VA Budget Earns High Praise 2Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite, and the HealthShares(TM) Diagnostics Indexes 2
(Date:7/24/2014)... -- Talyst, a market leader in pharmacy automation, will ... Veterans Homes (NASVH) Summer Conference in Charleston, ... is to ensure that each and every eligible US ... and respect which they have earned by their service ... Dispensing System, Talyst can help State Veterans Homes increase ...
(Date:7/24/2014)... 24, 2014  The American Association for Homecare ... mission to help address audit issues in the ... to be the information technology lead in shaping ... provider of billing and business management solutions for ... expertise to support this important initiative on behalf ...
(Date:7/24/2014)... CAMPBELL, Calif. , July 24, 2014 /PRNewswire/ ... the development of novel interventional devices to facilitate ... United States Patent and Trademark Office has issued ... core technology behind the company,s Lazarus Cover TM ... The Lazarus ReCover is a single-component stent-retriever ...
Breaking Medicine Technology:Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2
... 8, 2012 In the Middle East and ... in the MENA region are among the top 10 globally ... Arab Emirates, Bahrain, Egypt, Kuwait, Oman and Saudi Arabia. The ... percent of its total health care expenditure and expenditure averages ...
... Corporation (OTCBB: POSC), through its wholly owned subsidiary, ... announce the execution of a Memorandum of Understanding ... Troitsk, Russia. MIT and INR will collaborate on ... exercise in 2012.  A key goal of the ...
Cached Medicine Technology:Meeting of the Region's Top Diabetes Experts in Dubai this March 2Positron Completes Agreement With Institute of Nuclear Research, Troitsk, Russia for Additional Strontium-82 Supply 2Positron Completes Agreement With Institute of Nuclear Research, Troitsk, Russia for Additional Strontium-82 Supply 3
This kit has been designed for the quantitative,determination of total immunoreactive intact PTH (Total,Intact PTH) in blood samples. The Total Intact PTH,level is the sum of PTH (1-84) and N-t...
Fully automated immunochemiluminometric assay for the rapid intraoperative,measurement of Intact PTH 1-84 using human serum or EDTA plasma....
... exclusively distributed by Medtronic, sets the ... intra-operative imaging with surgical navigation in ... is one of the most comprehensive ... Exceptional image quality from a low-field ...
... nm and 940 nm) laser system is ... solid-state laser quickly and effectively treats vascular ... offers the clinical versatility to precisely target ... vessels in a convenient, affordable package. , ...
Medicine Products: